Neoadjuvant and adjuvant toripalimab for high-risk locoregionally advanced nasopharyngeal carcinoma: A randomized, double-blind, placebo-controlled phase 2 trial

被引：0
|
作者：
Liu, Sai Lan
Mai, Hai-Qiang
Wen, Dongxiang
Yang, Jin-Hao
Guo, Shan-Shan
Liu, Li-Ting
Luo, Mei-Juan
Liang, YuJing
Sun, Xue-Song
Li, Xiao-Yun
Luo, Dong-Hua
Li, Ji-Bin
Wang, Pan
Guo, Ling
Mo, Hao-Yuan
Sun, Rui
Zhao, Chong
Xu, Rui-Hua
Tang, Lin-Quan
Chen, Qiu-Yan
机构：
[1] Sun Yat sen Univ, Dept Nasopharyngeal Carcinoma, Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat sen Univ, Canc Ctr, Guangzhou, Peoples R China
[3] Sun Yat sen Univ, Dept Nasopharyngeal Carcinoma, Collaborat Innovat Ctr Canc Med,Canc Ctr, State Key Lab Oncol South China,Guangdong Key Lab, Guangzhou, Peoples R China
[4] Sun Yat sen Univ, Clin Trials Ctr, Canc Ctr, Guangzhou, Peoples R China
[5] Sun Yat sen Univ, Sun Yat sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6084
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase III study of apatinib in advanced gastric cancer: A randomized, double-blind, placebo-controlled trial.
    Qin, Shukui
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma
    Brighton, Timothy A.
    Khot, Amit
    Harrison, Simon J.
    Ghez, David
    Weiss, Brendan M.
    Kirsch, Andres
    Magen, Hila
    Gironella, Mercedes
    Oriol, Albert
    Streetly, Matthew
    Kranenburg, Britte
    Qin, Xiang
    Bandekar, Rajesh
    Hu, Peter
    Guilfoyle, Mary
    Qi, Ming
    Nemat, Sepideh
    Goldschmidt, Hartmut
    CLINICAL CANCER RESEARCH, 2019, 25 (13) : 3772 - 3775
  • [33] Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial
    Ma, Jun
    Sun, Ying
    Liang, Ye-Lin
    Shen, Liangfang
    Hu, Weihan
    Hu, Guangyuan
    Xie, Fangyun
    Huang, Ying
    Zou, Guorong
    Zhang, Ning
    Chen, Chuanben
    Chen, Xiaozhong
    Zhu, Xiaodong
    Yuan, Yawei
    Yang, Kunyu
    Jin, Feng
    Hong, Shu-Bin
    Zhao, Hongyun
    Li, Ji-Bin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA6000 - LBA6000
  • [34] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [35] Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
    Motzer, Robert J.
    Escudier, Bernard
    Oudard, Stephane
    Hutson, Thomas E.
    Porta, Camillo
    Bracarda, Sergio
    Gruenwald, Viktor
    Thompson, John A.
    Figlin, Robert A.
    Hollaender, Norbert
    Urbanowitz, Gladys
    Berg, William J.
    Kay, Andrea
    Lebwohl, David
    Ravaud, Alain
    LANCET, 2008, 372 (9637) : 449 - 456
  • [36] Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicenter, randomized controlled trial.
    Ma, Jun
    Chen, Yu-Pei
    Sun, Ying
    Zhou, Qin
    Yang, Kun-Yu
    Jin, Feng
    Zhu, Xiao-Dong
    Shi, Mei
    Hu, Guoqing
    Sun, Yan
    Wu, Hong-Fen
    Wu, Hui
    Lin, Qin
    Wang, Hui
    Tian, Ye
    Zhang, Ning
    Wang, Xicheng
    Shen, Liangfang
    Xie, Fangyun
    Liu, Xu
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] A randomized, double-blind, placebo-controlled trial: Paroxetine controlled release in fibromyalgia
    Patkar, AA
    Masand, PS
    Jiang, W
    Krulewicz, S
    Dube, E
    Purcell, C
    McMorran, C
    Peindl, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S319 - S320
  • [38] Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
    Kordes, Sil
    Pollak, Michael N.
    Zwinderman, Aeilko H.
    Mathot, Ron A.
    Weterman, Mariette J.
    Beeker, Aart
    Punt, Cornelis J.
    Richel, Dick J.
    Wilmink, Johanna W.
    LANCET ONCOLOGY, 2015, 16 (07) : 839 - 847
  • [39] Doxycycline in Creutzfeldt-Jakob disease: A phase 2, randomized, double-blind, placebo-controlled trial
    Brandel, Jean-Philippe
    Marcon, Gabriella
    Coudert, Mathieu
    Tettamanti, Mauro
    Welaratne, Arlette
    Giacone, Georgio
    Azimi, Shohreh
    Pietrini, Vladimiro
    Fabreguettes, Jean-Roch
    Imperiale, Daniele
    Aucan, Christophe
    Lucca, Ugo
    Mallet, Alain
    Salmona, Mario
    Zerr, Inga
    Redaelli, Veronica
    Forloni, Gianluigi
    Haik, Stephane
    Tagliavini, Fabrizio
    PRION, 2013, 7 : 62 - 62
  • [40] Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial
    Abebaw Fekadu
    Miraf Mesfin
    Girmay Medhin
    Atalay Alem
    Solomon Teferra
    Tsehaysina Gebre-Eyesus
    Teshale Seboxa
    Abraham Assefa
    Jemal Hussein
    Martha T Lemma
    Christina Borba
    David C Henderson
    Charlotte Hanlon
    Teshome Shibre
    Trials, 14
12345